Skip to content

Nais Wrist Blood Pressure Meter

by King & Spalding

510(k) K942423

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK942423 Date15 Feb 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXN
Device Class
Class II
Regulation
21 CFR Part 870.1130
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Nais Wrist Blood Pressure Meter is a noninvasive blood pressure measurement device designed to measure systolic, diastolic, and mean arterial pressure. It operates by using transducers placed on the wrist to derive pressure readings from the user’s radial artery. This type of device is classified under the FDA’s product code DXN and falls within the cardiovascular specialty category. Its purpose is to provide accurate, real-time blood pressure monitoring for clinical or home use.

This device is supplied as a single-use or reusable unit, depending on manufacturer specifications not detailed in the submission. It is intended for use in clinical settings, including hospitals, outpatient clinics, and home monitoring environments. The device received FDA 510(k) clearance under the traditional review pathway, with a clearance date of February 15, 1995, and is classified as a Class II medical device. No additional sterility or MRI safety information is provided in the available data.

Other devices from King & Spalding

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • How does the Nais Wrist Blood Pressure Meter measure blood pressure?

    The Nais Wrist Blood Pressure Meter uses transducers placed on the wrist to detect pressure waves from the radial artery. By analyzing these waves, the device calculates systolic, diastolic, and mean arterial pressure in real time, providing accurate readings for monitoring.

  • Is the Nais Wrist Blood Pressure Meter intended for single-use or reusable applications?

    The manufacturer’s specifications for single-use or reusable use are not detailed in the available data. However, the device is designed for clinical settings, including hospitals, outpatient clinics, and home monitoring, so its intended use may vary based on facility protocols and manufacturer guidelines.

  • What types of environments is the Nais Wrist Blood Pressure Meter approved for?

    This device is approved for use in clinical settings such as hospitals, outpatient clinics, and home monitoring environments. Its noninvasive design and FDA clearance under the cardiovascular specialty category (DXN) make it suitable for both professional and patient self-monitoring.

  • Does the Nais Wrist Blood Pressure Meter require any special storage conditions?

    The available data does not specify any special storage requirements for the Nais Wrist Blood Pressure Meter. However, standard medical device storage practices—such as protecting it from extreme temperatures, moisture, and physical damage—should be followed to maintain accuracy and functionality.

  • What regulatory pathway was used for FDA clearance of this device?

    The Nais Wrist Blood Pressure Meter received FDA 510(k) clearance under the traditional review pathway, demonstrating substantial equivalence to a predicate device. The clearance was granted on February 15, 1995, and it is classified as a Class II medical device under the FDA’s product code DXN.